Výsledky vyhledávání - Mojcik, Christopher
- Zobrazuji výsledky 1 - 5 z 5
-
1
-
2
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study Autor Tanaka, Yoshiya, Sugiyama, Naonobu, Toyoizumi, Shigeyuki, Lukic, Tatjana, Lamba, Manisha, Zhang, Richard, Chen, Connie, Stock, Thomas, Valdez, Hernan, Mojcik, Christopher, Fan, Haiyun, Deng, Chenhui, Yuasa, Hirotoshi
Vydáno 2019Text -
3
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial Autor Winthrop, Kevin L., Wouters, Ann G., Choy, Ernest H., Soma, Koshika, Hodge, Jennifer A., Nduaka, Chudy I., Biswas, Pinaki, Needle, Elie, Passador, Sherry, Mojcik, Christopher F., Rigby, William F.
Vydáno 2017Text -
4
Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis Autor van Vollenhoven, Ronald, Lee, Eun Bong, Strengholt, Sander, Mojcik, Christopher, Valdez, Hernan, Krishnaswami, Sriram, Biswas, Pinaki, Lazariciu, Irina, Hazra, Anasuya, Clark, James D., Hodge, Jennifer, Wang, Lisy, Choy, Ernest
Vydáno 2019Text -
5
Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers Autor Weinhold, Kent J., Bukowski, Jack F., Brennan, Todd V., Noveck, Robert J., Staats, Janet S., Lin, Liwen, Stempora, Linda, Hammond, Constance, Wouters, Ann, Mojcik, Christopher F., Cheng, John, Collinge, Mark, Jesson, Michael I., Hazra, Anasuya, Biswas, Pinaki, Lan, Shuping, Clark, James D., Hodge, Jennifer A.
Vydáno 2018Text